Drug Discovery Solutions
-
Cytokine Mouse Models: AAALAC And Worldwide Shipping
9/30/2025
Humanized mouse models expressing cytokine genes enable research into immune response mechanisms, inflammation, immunotherapy, and drug screening for autoimmune, infectious, and cancer-related diseases.
-
Phosphoramidite Chemistry Capabilities For Oligonucleotide Synthesis
6/18/2025
Accelerate your research and development with high-quality, custom phosphoramidite synthesis backed by decades of proven chemistry and scalable precision.
-
Transient Expression Platform: discoCHO
10/4/2024
Learn how this transient platform accelerates biologics production, seamlessly transitioning from discovery to stable CHO-K1, ensuring scalability, and reducing risks in manufacturing therapeutic biologics.
-
DNA2.0 - Gene Optimization And Synthesis
2/13/2024
ATUM is building on DNA2.0's reputation for rapid, reliable and accurate DNA synthesis. Using our proprietary GeneGPS® and VectorGPS® platforms we design constructs optimized to express in your system, whether that's a single gene in E. coli, a metabolic pathway in yeast or a complex bispecific antibody in mammalian cells.
-
TARGATTâ„¢ HEK293 Kits
9/30/2025
Accelerate cell line development for library creation and protein expression with efficient TARGATT™ large knock-in technology.
-
Bioengineering Solutions Using A Fully Integrated Ecosystem
5/30/2023
Find solutions to meet your gene, protein, antibody, or cell line needs using two gene synthesis platforms that enable the design of constructs optimized for maximal expression/yield in your system.
-
Drug Substance Synthesis And Manufacturing
3/3/2022
We take an agile and flexible approach with our customers programs, offering bespoke drug substance synthesis and manufacturing, helping to accelerate molecules from candidate selection to clinical proof-of-concept and onwards towards commercial scale.
-
Scientific Insights Lab Simplifying The Journey From Molecule To Market
Drug development programs should aid customers in the successful mitigation of technical and regulatory risks to ensure drug products move swiftly through the regulatory approval process and into commercialization. Get service and support to help pharmaceutical and biopharmaceutical manufacturers Simplify the Journeyâ„¢ from molecule to market.
-
Accelerating Oligonucleotides Discovery And Development Programs
6/13/2025
Leverage advanced oligonucleotide synthesis capabilities to accelerate the development of ASOs, siRNA, miRNA, and other nucleic acid-based therapeutics.
-
CRISPR Mouse Model Generation
9/30/2025
We provide genetically engineered mouse and rat models for biomedical research and preclinical drug discovery.